Bovilis Ringvac
Country: Germany
Language: English
Source: HMA (Heads of Medicines Agencies)
Summary of Product characteristics
(SPC)
29-09-2012
Some documents for this product are not currently available, you can send a request to our customer service and we will notify you as soon as we are able to obtain them.
Send request.
Send request.
Active ingredient:
trichophyton verrucosum 7000000 IU/ml
Available from:
Intervet Deutschland GmbH
ATC code:
QI02AP01
Pharmaceutical form:
Powder and solvent for suspension for injection
Therapeutic group:
Trichophyton vaccine
Therapeutic area:
Cattle Food
Authorization date:
2008-03-11
Summary of Product characteristics
June 2008
FEHLER! VERWEISQUELLE KONNTE NICHT GEFUNDEN WERDEN.
BOVILIS® RINGVAC
FEHLER! VERWEISQUELLE KONNTE NICHT GEFUNDEN WERDEN.
I.B.
SUMMARY OF PRODUCT CHARACTERISTICS
1.
NAME OF THE VETERINARY MEDICINAL PRODUCT
Bovilis Ringvac, lyophilisate for suspension for injection, for cattle
2.
QUALITATIVE AND QUANTITATIVE COMPOSITION
Per 1 ml of vaccine:
ACTIVE SUBSTANCE:
Attenuated _Trichophyton verrucosum,_ strain LTF-130
9 x 10
6
and
21 x 10
6
viable
microconidia.
EXCIPIENTS:
For a full list of excipients, see section 6.1.
3.
PHARMACEUTICAL FORM
Lyophilisate and solvent for suspension for injection.
4.
CLINICAL PARTICULARS
4.1
TARGET SPECIES
Cattle.
4.2
INDICATIONS FOR USE, SPECIFYING THE TARGET SPECIES
Active immunisation of calves and cattle at risk of infection or calves and cattle suffering
from dermatophytosis induced by _Trichophyton verrucosum_. The prophylactic
vaccination reduces clinical signs of _Trichophyton verrucosum_ induced dermatophytosis
while the therapeutic use results in a 2-fold
faster recovery of animals which already
show clinical signs of disease.
Protective immunity is present within 3 weeks after vaccination and was shown to last for
at least one year in a laboratory study. Field experience shows that if consequent herd
immunisation is practised generally no revaccinations are required (cf. section 4.9).
4.3
CONTRAINDICATIONS
Animals with fever and / or with dermatophytosis -independent symptoms of an
infectious disease, as well as animals that are treated with corticosteroids, must be
excluded from vaccination.
4.4
SPECIAL WARNINGS
None.
4.5
SPECIAL PRECAUTIONS FOR USE
Read the complete document
